Zealand Pharma A/S
  • About Zealand
    • About Us
    • Disease Focus
    • History
    • Corporate Management
    • Corporate Governance
    • Corporate Social Responsibility
    • Board of Directors
    • Videos About Zealand
    • Transparency Reporting
  • R&D
    • Our Focus
    • Product Pipeline
    • Glepaglutide for SBS
    • Dasiglucagon for BHAP Systems
    • Dasiglucagon for CHI
    • BI 456906 GLP-1/GLU Dual Agonist
    • Amylin Analogue, ZP8396
    • In-licensing
    • What are Peptides?
    • Peptide Platform Video
  • Investor
    • Investor Relations
    • Corporate Presentation
    • Stock Information
    • Shareholder Portal
    • Financial Calendar
    • Financial Reports
    • Events
    • Annual General Meeting
    • Conference Calls
    • SEC Filings
    • Analyst Coverage
  • Media
    • Zealand News
    • Media Inquiry
    • Downloads
  • Careers
    • Zealand as a Workplace
    • Meet Us
    • Positions
    • Personal Data in the Recruitment Process
  • Contact
  • Zealand News
  • Media Inquiry
  • Downloads

Downloads

Corporate Management

Adam Steensberg, President and Chief Executive Officer
Christina Sonnenborg Bredal, Senior Vice President and Global Head of People & Organization
David Kendall, Chief Medical Officer
Henriette Wennicke
Henriette Wennicke, Chief Financial Officer
Ivan Møller, Executive Vice President and Chief Operating Officer
Ravinder Chahil, Vice President and General Counsel

Research and Development

Labphoto (highress jpg)

Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
Labphoto (highress jpg)
For Press RGB_01.eps

Zealand Pharma A/S     Sydmarken 11      2860 Søborg Denmark     Tel +45 88 77 36 00     info@zealandpharma.com

Legal disclaimer     Privacy policy